Retraction Note: Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis [Mol Biol Rep, (2014), 41, (3991-3999), DOI 10.1007/s11033-014-3267-6];Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: A meta-analysis

Molecular Biology Reports

Volumn 41, Issue 6, 2014, Pages 3991-3999

  Wang, He Ling ^a   Zhang, Yu ^a   Liu, Peng ^a   Zhou, Ping Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Meta analysis; Methylation; RASSF1A

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AFRICAN; ARTICLE; ASIAN; CANCER GRADING; CANCER STAGING; CAUCASIAN; COHORT ANALYSIS; COLORECTAL CANCER; ETHNIC GROUP; ETHNICITY; GENDER; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; METHYLATION; PROMOTER REGION; RASSF1A GENE; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOGENESIS; COLORECTAL TUMOR; DNA METHYLATION; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; PATHOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOGENESIS; COLORECTAL NEOPLASMS; DNA METHYLATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84902378305     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-015-3890-x     Document Type: Erratum

References (29)

1. Abouzeid HE, Kassem AM, Abdel Wahab AH, El-mezayen HA, Sharad H, Abdel Rahman S (2011) Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors. Tumour Biol 32:845-852. doi:10.1007/s13277-011-0156-7
2. Amin KS, Banerjee PP (2012) The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog 11:3. doi:10.4103/1477-3163.93000
3. Chen SP, Wu CC, Huang SY, Kang JC, Chiu SC, Yang KL, Pang CY (2012) b-Catenin and K-ras mutations and RASSF1A promoter methylation in Taiwanese colorectal cancer patients. Genet Test Mol Biomark 16:1277-1281. doi:10.1089/gtmb 2012.0126
4. Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P (2010) Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 172:1000-1014. doi:10.1093/aje/kwq245
5. Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D et al (2010) Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess 14:1-206. doi:10.3310/hta14320
6. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP (2000) Epigenetic inactivation of a ras association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25:315-319. doi:10.1038/77083 (Pubitemid 30437320)
7. Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Koessler T, Pharoah P, Schafmayer C et al (2013) Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut 62:871-881. doi:10.1136/gutjnl-2011-300537
8. Fernandes MS, Carneiro F, Oliveira C, Seruca R (2013) Colorectal cancer and RASSF family-a special emphasis on RASSF1A. Int J Cancer 132:251-258. doi:10.1002/ijc.27696
9. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125:171-180. doi:10.1002/ijc.24343
10. Kang HJ, Kim EJ, Kim BG, You CH, Lee SY, Kim DI, Hong YS (2012) Quantitative analysis of cancer-associated gene methylation connected to risk factors in Korean colorectal cancer patients. J Prev Med Public Health 45:251-258. doi:10.3961/jpmph.2012.45.4.251
11. Kimura N, Moribe T, Iizuka N, Miura T, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Oka M (2009) Rapid and quantitative detection of CpG-methylation status using TaqMan PCR combined with methyl-binding-domain polypeptide. Clin Biochem 42:1113-1122. doi:10.1016/j.clinbiochem.2009.03.017
12. Lao VV, Grady WM (2011) Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 8:686-700. doi:10.1038/nrgastro.2011.173
13. Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, Jiang JH, Guo C, Zabarovsky E et al. (2005) High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther 4:1116-1122. http://www.ncbi.nlm.nih. gov/pubmed/16096369 (Pubitemid 41598567)
14. Shin A, Joo J, Bak J, Yang HR, Kim J, Park S, Nam BH (2011) Site-specific risk factors for colorectal cancer in a Korean population. PLoS ONE 6:e23196. doi:10.1371/journal.pone.0023196
15. Sinha R, Hussain S, Mehrotra R, Kumar RS, Kumar K, Pande P, Doval DC, Basir SF et al (2013) Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population. PLoS ONE 8:e60142. doi:10.1371/journal.pone.0060142
16. Tommasi S, Pinto R, Petriella D, Pilato B, Lacalamita R, Santini D, Zito F, Colucci G et al (2011) Oncosuppressor methylation: a possible key role in colon metastatic progression. J Cell Physiol 226:1934-1939. doi:10.1002/jcp. 22524
17. Hu JL, Chen Y, Liu S, Chen SL, Jiang MJ (2010) Relationship of rassf1a promoter methylation with expressions of cyclin d1 and p53 in colorectal cancer. Chin J Cancer Biother 17:444-449. doi:10.3872/j.issn.1007-385X.2010.04.016
18. Stang A (2010) Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603-605. doi:10.1007/s10654-010-9491-z
19. Zintzaras E, Ioannidis JP (2005) Hegesma: genome search meta-analysis and heterogeneity testing. Bioinformatics 21:3672-3673. doi:10.1093/bioinformatics/ bti536 (Pubitemid 41264106)
20. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676-680. doi:10.1001/jama.295.6.676 (Pubitemid 43209069)
21. Li CJ, Yan L, Wen XG, Luo JB (2011) Expression and significance RASSF1A methylation and mrna in colorectal cancer. Shandong Med J 51:87-88. doi:10.3969/j.issn.1002-266X.2011.42.052
22. Wang XD, Wang HZ, Xu H, Liang GD, Zhang W, Zhu BP, Fang XD, Jiang HW (2011) Clinical significance of RASSF1A promoter methylation in colorectal cancer. Chin J Labor Diagn 15:1538-1539. doi:10.3969/j.issn.1007-4287.2011.09. 040
23. Yu ZH, Shi ZR, Gao Y, Wang YC, Su QS, Yu HJ, Liu C, Lin Y et al (2011) RASSF1A promoter hypermethylation of serum DNA in gastric and colorectal adenocarcinoma patients. Oncol Prog 9:555-560. doi:10.3969/j.issn.1672-1535. 2011.05.019
24. Miladi-Abdennadher I, Abdelmaksoud-Damak R, Ayadi L, Khabir A, Frikha F, Kallel L, Amouri A, Frikha M et al (2010) Hypermethylation of RARb2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Tumour Biol 31:503-511. doi:10.1007/s13277-010-0063-3
25. Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E, Franchi G, Morenghi E et al (2006) Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 95:1101-1107. doi:10.1038/sj.bjc.6603337 (Pubitemid 44606839)
26. Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R, Yamamoto H, Seruca R et al (2005) Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oncogene 24:7630-7634. doi:10.1038/sj.onc.1208906 (Pubitemid 41638038)
27. van Engeland M, Roemen GM, Brink M, Pachen MM, Weijenberg MP, de Bruine AP, Arends JW, van den Brandt PA et al (2002) K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 21:3792-3795. doi:10.1038/sj.onc.1205466 (Pubitemid 34620542)
28. Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, Issa JP, Hinoda Y et al. (2005) The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129:156-169. http://www.ncbi.nlm. nih.gov/pubmed/16012945 (Pubitemid 41002052)
29. Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S et al (2011) DNA hypermethylation in papillary renal cell carcinoma. BJU Int 107:664-669. doi:10.1111/j.1464-410X. 2010.09468.x